Helen I. Mcshane

Old Road Campus Research Building, Roosevelt Drive
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 194 publications

Correction: Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Correction: Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Journal: Scientific reports

Published: July 27, 2026

Lessons from another negative tuberculosis vaccine trial.

Lessons from another negative tuberculosis vaccine trial.

Journal: The Lancet. Infectious diseases

Published: July 14, 2026

Conference report: airway mucosal sampling and immune analysis.

Conference report: airway mucosal sampling and immune analysis.

Journal: Vaccine

Published: March 20, 2026

Automated virtual reality therapy to treat needle fears (trypanophobia) in adolescents in England: a proof-of-concept cohort study and a Phase II randomised controlled trial.

Automated virtual reality therapy to treat needle fears (trypanophobia) in adolescents in England: a proof-of-concept cohort study and a Phase II randomised controlled trial.

Journal: EClinicalMedicine

Published: March 17, 2026

Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.

Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.

Journal: Cell reports. Medicine

Published: February 11, 2026

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Journal: Frontiers in immunology

Published: February 09, 2026

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Journal: Scientific reports

Published: November 04, 2025

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Journal: Scientific reports

Published: November 04, 2025

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.

The influence of murine cytomegalovirus infection on susceptibility to mycobacterial infection.

Journal: iScience

Published: September 08, 2025

MetE: a promising protective antigen for tuberculosis vaccine development.

MetE: a promising protective antigen for tuberculosis vaccine development.

Journal: Frontiers in immunology

Published: March 13, 2025

Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeutics.

Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeutics.

Journal: Contemporary clinical trials communications

Published: December 13, 2024

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

Journal: Frontiers in immunology

Published: December 05, 2024

Showing 1-12 of 194

Last Updated: 09/26/2026